Robot- assisted retroperitoneal lymphadenectomy in testicular cancer treatment

Postgraduate Thesis uoadl:1327356 669 Read counter

Unit:
Κατεύθυνση Ελάχιστα Επεμβατική Χειρουργική, Ρομποτική Χειρουργική και Τηλεχειρουργική με εξειδίκευση στην Χειρουργική των Μεταμοσχεύσεων των οργάνων
Library of the School of Health Sciences
Deposit date:
2017-01-31
Year:
2017
Author:
Tselos Angelos
Supervisors info:
Αλέξανδρος Παπαλάμπρος, Λέκτορας, Ιατρική σχολή, ΕΚΠΑ
Χρήστος Π. Τσιγκρής, Ομότιμος Καθηγητής, Ιατρική σχολή, ΕΚΠΑ
Θεόδωρος Διαμαντής, Καθηγητής, Ιατρική σχολή, ΕΚΠΑ
Original Title:
Robot- assisted retroperitoneal lymphadenectomy in testicular cancer treatment
Languages:
English
Translated title:
Robot- assisted retroperitoneal lymphadenectomy in testicular cancer treatment
Summary:
Aims: Retroperitoneal lymph node dissection (RPLND) in testicular cancer is a documented treatment along with active surveillance and chemotherapy. The present study aims to summarize the current evidence on the use of Robot-assisted RPLND (RARPLND), with emphasis oncological equality and procedure safety in clinical stage I and II testicular cancer in comparison with the laparoscopic and open approach.
Materials and Methods: A thorough search was conducted in the existing literature focusing on reports with outcomes of Robot – Assisted Retroperitoneal Lymph Node Dissection for clinical stage I-IIB testicular tumor. The studies were assessed based on eligibility criteria.
Results: 11 studies complied with the inclusion criteria, including 116 patients. The average follow up of 21,2 months showed no retroperitoneal recurrence. The median lymph node yield was 22,3, and the overall lymph node positive rate was 26%. Complications were encountered in 8% of the patients. Antegrade ejaculation was maintained in 95,5%. The robotic approach showed similar results to the laparoscopic one and outer performed the open procedure in perioperative parameters.
Conclusions: Based on our analysis, relapse free survival, nodal yield and complication rates during RARPLND for clinical stage I-IIB are acceptable. Further studies are required in order to establish those findings and determine a possible benefit from the use of robotic approach.
Main subject category:
Health Sciences
Keywords:
Robot- assisted, RARPND, Retroperitoneal lymphadenectomy, Testicular cancer
Index:
No
Number of index pages:
0
Contains images:
No
Number of references:
62
Number of pages:
52
File:
File access is restricted only to the intranet of UoA.

Tselos_A_MSc_MIRS.pdf
888 KB
File access is restricted only to the intranet of UoA.